A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia

Diro, E; Blesson, S; Edwards, T; Ritmeijer, K; Fikre, H; Admassu, H; Kibret, A; Ellis, SJ; Bardonneau, C; Zijlstra, EE; Soipei, P; Mutinda, B; Omollo, R; Kimutai, R; Omwalo, G; Wasunna, M; Tadesse, F; Alves, F; Strub-Wourgaft, N; Hailu, A; Alexander,

Blesson, S (reprint author), Drugs Neglected Dis Initiat, Dept Res & Dev, Geneva, Switzerland.

PLOS NEGLECTED TROPICAL DISEASES, 2019; 13 (1):

Abstract

Background Visceral leishmaniasis (VL) in human immunodeficiency virus (HIV) co-infected patients requires special case management. AmBisome monothera......

Full Text Link